Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of lanreotide Autogel (90 and 120 mg), compared with Sandostatin LAR Depot (20 and 30 mg), in terms of the frequency of target symptom episodes, assessed by the change from baseline in the average daily number of episodes of the target symptom at Week 24.
Critère d'inclusion
- Treatment of clinical symptoms of carcinoid syndrome